[EN] TRICYCLIC COMPOUNDS AS TEC KINASE INHIBITORS<br/>[FR] COMPOSÉS TRICYCLIQUES À TITRE D'INHIBITEURS DE KINASES TEC
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2013153539A1
公开(公告)日:2013-10-17
The present invention is directed to tricyclic compounds of formula (I) as Tec kinase inhibitors, in particular ITK (interleukin-2 inducible tyrosine kinase) inhibitors. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders mediated by ITK.
Efficient Synthesis of Diastereomerically Pure Vicinal Diamines: <i>meso</i>-2,3-Bis(methylamino)butane and <i>cis</i>-1,2-Bis(methylamino)cycloalkanes